SONOBIRD
https://www.nct-dresden.de/en/trials/900-000002425
https://www.nct-dresden.de/@@site-logo/logo-nct.svg
SONOBIRD
Section
NCT
Category
Brain/CNS tumors
Subcategory
Glioblastoma
Trial Type
Adjuvant Therapy
Description for experts
- A randomized, open-label, multicenter, two-arm study of SonoCloud-9 combined with carboplatin versus standard lomustine (CCNU) or temozolomide (TMZ) therapy in patients with operable first recurrence of glioblastoma
- Implantable device that is used as a bone flap replacement after resection of the recurrence. Using specific ultrasound frequencies and a substance (microbubbles), the blood-brain barrier can be temporarily opened so that large-molecule chemotherapeutic agents, such as carboplatin, can also penetrate the tissue.
Description for laymen
- A randomized, open-label, multicenter, two-arm study of SonoCloud-9 combined with carboplatin versus standard lomustine (CCNU) or temozolomide (TMZ) therapy in patients with operable first recurrence of glioblastoma
- Implantable device that is used as a bone flap replacement after resection of the recurrence. Using specific ultrasound frequencies and a substance (microbubbles), the blood-brain barrier can be temporarily opened so that large-molecule chemotherapeutic agents, such as carboplatin, can also penetrate the tissue.
JSON Data
{
"short_title": "SONOBIRD",
"data_mode": "900",
"data_mode_number": "000002425",
"official_title": "SonoCloud for Bbb opening In gbm Recurrent Disease",
"accrual_state": "running",
"therapeutic_value": "therapeutic",
"therapieansatz_value": "kurativ",
"therapieintervention_value": "adjuvant",
"therapielinie_value": "second",
"ctgov_number": null,
"eudract_number": null,
"general_contact_email": "andrea.sorokin@ukkd.de",
"general_contact_phone": "0351-4584828",
"hauptpruefer_dd_name": null,
"description_laie_de": "- Eine randomisierte, offene, multizentrische, zweiarmige Studie mit SonoCloud-9 kombiniert mit Carboplatin versus Standard Lomustin (CCNU) oder Temozolomid (TMZ) Therapie bei Patienten mit operablem ersten Rezidiv eines Glioblastoms\r\n- Implantierbares Device, das nach Resektion des Rezidivs als Knochendeckelersatz eingesetzt wird. Mittels spezifischer Ultraschallfrequenzen und einer Substanz (microbubbles) l\u00e4sst sich die Blut-Hirn-Schranke vor\u00fcbergehend \u00f6ffnen, sodass auch gro\u00dfmolekulare Chemotherpeutika in das Gewebe eindringen k\u00f6nnen, wie z.B. Carboplatin.",
"description_laie_en": "- A randomized, open-label, multicenter, two-arm study of SonoCloud-9 combined with carboplatin versus standard lomustine (CCNU) or temozolomide (TMZ) therapy in patients with operable first recurrence of glioblastoma\r\n- Implantable device that is used as a bone flap replacement after resection of the recurrence. Using specific ultrasound frequencies and a substance (microbubbles), the blood-brain barrier can be temporarily opened so that large-molecule chemotherapeutic agents, such as carboplatin, can also penetrate the tissue.",
"description_expert_de": "- Eine randomisierte, offene, multizentrische, zweiarmige Studie mit SonoCloud-9 kombiniert mit Carboplatin versus Standard Lomustin (CCNU) oder Temozolomid (TMZ) Therapie bei Patienten mit operablem ersten Rezidiv eines Glioblastoms\r\n- Implantierbares Device, das nach Resektion des Rezidivs als Knochendeckelersatz eingesetzt wird. Mittels spezifischer Ultraschallfrequenzen und einer Substanz (microbubbles) l\u00e4sst sich die Blut-Hirn-Schranke vor\u00fcbergehend \u00f6ffnen, sodass auch gro\u00dfmolekulare Chemotherpeutika in das Gewebe eindringen k\u00f6nnen, wie z.B. Carboplatin.",
"description_expert_en": "- A randomized, open-label, multicenter, two-arm study of SonoCloud-9 combined with carboplatin versus standard lomustine (CCNU) or temozolomide (TMZ) therapy in patients with operable first recurrence of glioblastoma\r\n- Implantable device that is used as a bone flap replacement after resection of the recurrence. Using specific ultrasound frequencies and a substance (microbubbles), the blood-brain barrier can be temporarily opened so that large-molecule chemotherapeutic agents, such as carboplatin, can also penetrate the tissue.",
"rechtsgrundlage_value": "MPG",
"phase_amg_value": null,
"main_cat_id": 8,
"sub_cat_id": 42
}